422
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Clarification of trial end points presented in a recent review of linaclotide

&
Pages 13-14 | Published online: 10 Jan 2014

References

  • Roque MV, Camilleri M. Linaclotide, a synthetic guanylate cyclase C agonist, for the treatment of functional gastrointestinal disorders associated with constipation. Expert Rev. Gastroenterol. Hepatol.5(3), 301–310 (2011).
  • FDA Center for Drug Evaluation and Research. Guidance for Industry: Irritable Bowel Syndrome: Clinical Evaluation of Products for Treatment (Draft IBS Guidance). US FDA, Center for Drug Evaluation and Research, MD, USA (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.